The association between venous thromboembolism (VTE) and malignancy has been demonstrated by a large number of studies, cancer is associated with thrombosis, which also has an impact on the proliferation and extension of cancer. The pathogenesis of cancer-related venous thromboembolism is complex, and the formation of thrombosis is the result of the complex interaction of multiple factors. This article reviews the pathological mechanism and related factors of venous thromboembolism associated with oral maxillofacial-head and neck malignancies as follows, by discussing the risk factors of VTE in patients with o oral maxillofacial-head and neck malignancies, more clearly understands the pathogenesis and risk factors of VTE associated with it, better prevent VTE in clinical practical application, strengthen risk assessment, improve the understanding of VTE related factors, do a good job in the education of patients and medical staff, individualized management and anticoagulant therapy for patients, close follow-up and regular review after treatment, so as to improve the life treatment of patients, prolong the survival time, and reduce the occurrence of VTE associated with oral maxillofacial head and neck malignancies.

Qi He, Ruican Nie, Ayidana Wulaerbieke, Amannisahan Jiapaer, Bin Ling. Risk factors of venous thromboembolism associated with Oral maxillofacial-head and neck cancer. International Journal of Frontiers in Medicine (2023), Vol. 5, Issue 1: 71-76. https://doi.org/10.25236/IJFM.2023.050113.

[1] Leiva O, et al, Cancer and thrombosis: new insights to an old problem [J]. Med -Vasc, 2020. 45 (6S): 6S8-6S16

[2] Zhao Jichun, Wu Zhoupeng, Guo Qiang. Interpretation of Guidelines for the Treatment of Tumor-associated Venous Thromboembolism [J]. Chinese Journal of Bases and Clinics in General Surgery, 2020, 27 (04): 407-411.

[3] Citla Sridhar D, Abou-Ismail MY, Ahuja SP.Central venous catheter-related thrombosis in children and adults [J]. Thromb Res, 2020, 187:103-112.

[4] Blom JW, Doggen CJ, Osanto S, et al. Malignancies, pro-thrombotic mutations, and the risk of venous thrombosis [J]. JAMA, 2005, 293 (6): 715-722.

[5] LeeJ, Alexand A, Higgins K, et al.The Sunnubrook experience: review of deep vein thrombosis and pulmonary embolism in otolartngology [J].JOtolarynhol Head Neck Surg, 2008, 37:547- 551

[6] Lyman GH, Culakova E, Poniewierski MS, et al. Morbidity, mortality and costs associated with venous thromboembolism in hospitalized patients with cancer [J]. Thromb Res, 2018, 164 (Suppl 1): S112-118.

[7] Guo Wei. A Review of Clinical Application of Targeted Therapy for Oral and Maxillofacial Head and Neck Malignant Tumors [J]. Journal of Oral and Maxillofacial Surgery, 2020, 30 (03): 132-136.

[8] MB, Holmstrom B, Angelini D, Ashrani A, Elshoury A, Fanikos J, Fertrin KY, Fogerty AE, Gao S, Goldhaber SZ, Gundu K, Ibratil I, Kraut E, Leavitt AD, Lee A, Lee JT, Lim M, Mann J, Martin K, McMahon B, Moriarty J, Morton C, Ortel TL, Paschal R, Schaeyen J, Shatfer S, Siddiqi T, Associated Sudheiff D, Williams E, Hollinger L, Nguolic MQ. Cancer-VVendra Disease, Version 2.2021, Thromboboid Disease NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Netw. 2021 Oct 15; 19 (10): 1181-1201.

[9] Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality for 36 Cancers in 185 Worldwide Countries. CA Cancer J Clin. 2021 May; 71 (3): 209-249.

[10] Rhoten B, Ridner S, Dietrich M.Body image, social anxiety, and viral related t-umors in patients with head and neck cancer [J].0ncol Nurs Forum, 2013, 40 (6): E438

[11] Feng Jialian, Wen Zhong. Current Status and Application of Organoid Studies in Head and Neck Malignant Tumors [J]. Chinese Journal of Otorhinolaryngology and Skull Base Surgery, 2021, 27 (04): 488-492.

[12] Mulder FI, Horváth-Puhó E, van Es N, van Laarhoven HWM, Pedersen L, Moik F, Ay C, Büller HR, Sørensen HT. Venous thromboembolism in cancer patients: a population-based cohort study. Blood. 2021 Apr 8; 137 (14): 1959-1969.

[13] Innis WP, Anderson TD. Deep venous thrombosis and pulmonary embolism in otolaryngologic patients. Am J Otolaryngol. 2009; 30 (4): 230-233.

[14] Shuman AG, Hu HM, Pannucci CJ, Jackson CR, Bradford CR, Bahl V. Stratifying the risk of venous thromboembolism in otolaryngology. Otolaryngol Head Neck Surg. 2012; 146 (5): 719-724.

[15] Garritano FG, Lehman EB, Andrews GA. Incidence of venous thromboembolism in otolaryngology-head and neck surgery. JAMA Otolaryngol Head Neck Surg. 2013; 139 (1): 21-27.

[16] Caemer JD, Shuman AG, Brenner MJ.Antithrombotic Therapy for Venous Thromboembolism and Prevention of Thrombosis in Otolaryngology -Head and Neck Surgery: State of the Art Review [J]. Otolaryngology -Head and Neck Surg, 2018, 158 (4) Tolaryngology - Head and Neck Surgery: 627-636

[17] Ahmad, F. I., & Clayburgh, D. R. (2016). Venous thromboembolism in head and neck cancer surgery. Cancers of the head & neck, 1, 13. https://doi.org/10.1186/s41199-016-0014-9

[18] Thai L, McCarn K, Stott W, et al. Venous thromboembolism in patients with head and neck cancer after surgery. Head Neck. 2013; 35 (1): 4 – 9.

[19] Khorana AA.Venous thromboembolism and prognosis in cancer [J]. Thrombosis -Res, 2010, 125 (6): 490-493.

[20] Wang Qiaoyu, Wu Mingfen, Liu Xin, Wang Xiaoyan, Chen Yaolong, Zhao Zhigang.2021 Chinese Guidelines for the Selection and Pharmaceutical Care of Anticoagulant Drugs for the Prevention and Treatment of Venous Thromboembolism [J]. Chinese Journal of Clinical Pharmacology, 2021, 37 (21): 2999-3016.

[21] Kushner A, West WP, Pillarisetty LS. Virchow Triad. 2021 Sep 14. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan –. PMID: 30969519.

[22] Trousseau A. Plegmasia alba dolens. Lectures on clinical medicine, delivered at the Hotel-Dieu, Paris. 1865; 5:281 – 332

[23] Zhen C, Wang Y, Wang H, Li D, Wang X. Multiple cerebral infarction underlying linked to cancer: a review of Trousseau syndrome-related cerebral infarction. Br J Hosp Med (Lond). 2021; 82 (5): 1-7.

[24] Tipirneni KE, Bauter L, Arnold MA, Audlin JA, Ryan J, Marzouk M. Association of Prolonged-Duration Chemoprophylaxis With Venous Thromboprophylaxis in High-Risk Patients With Head and Neck Cancer. JAMA Otolaryngol Head Neck Surg. 2021 Apr 1; 147 (4): 320-328.

[25] Clayburgh DR, Stott W, Cordiero T, et al. Prospective study of venous thromboembolism in patients with head and neck cancer after surgery. JAMA Otolaryngol Head Neck Surg. 2013; 139 (11): 1143-1150.

[26] LYMAN G H, KUDERER N M.Clinical practice guidelines for the treatment and prevention of cancer-associated thrombosis [J].Thromb Res, 2020, 191 Suppl 1: S79-S84

[27] Xiao Jian, Song Yexun, Tan Guolin. Clinical analysis of patients with venous thromboembolism after head and neck malignant tumor surgery [J]. Journal of Clinical Otorhinolaryngology Head and Neck Surgery, 2021, 35 (09): 779-783

[28] Sharma BK, Flick MJ, Palumbo JS.Cancer-Asociated Thrombosis: A Two-Way Stret [J].Semin Thromb Hemost, 2019, 45 (6): 559-568.

[29] Zhou Jing, Chen Xiaohong, Qin Mingzhao. Diagnosis and treatment analysis of patients with pulmonary embolism after head and neck malignant tumor surgery [J]. Department of Otorhinolaryngology, Head and Neck Surgery, China, 2015, 22 (10): 504-506.

[30] Zhao Jichun, Wu Zhoupeng, Guo Qiang, et al. Interpretation of Guidelines for the Treatment of Tumor-Associated Venous Thromboembolism [J]. Chinese Journal of General Surgery Foundation and Clinical Medicine, 2020.27 (04): Page 407-411.

[31] Vlodavsky, I.; Gross-Cohen, M.; Weissmann, M.; Ilan, N.; Sanderson, R.D. Opposing Functions of Heparanase-1 and Heparanase-2 in Cancer Progression. Trends Biochem. Sci. 2018, 43, 18 – 31.

[32] Kim, Ann S et al. "Mechanisms and biomarkers of cancer-associated thrombosis." Translational research: the journal of laboratory and clinical medicine vol. 225 (2020): 33-53.

[33] Ma Yuyuan, Xiao Haijuan, Yang Lin, Fu Jingya. Progress in the study of risk factors of tumor venous thromboembolism [J/OL]. Journal of Medical Research: 1-6 [2023-01-08].

[34] Angchaisuksiri, Pantep et al. "Venous thromboembolism in Asia and worldwide: Emerging insights from GARFIELD-VTE." Thrombosis research vol. 201 (2021): 63-72.

[35] Nasser, Nicola J et al. "Potential Mechanisms of Cancer-Related Hypercoagulability." Cancers vol. 12, 3 566. 29 Feb. 2020

[36] Hamza MS, Mousa SA. Cancer-Associated Thrombosis: Risk Factors, Molecular Mechanisms, Future Management. Clin Appl Thromb Hemost. 2020; 26:1076029620954282.

[37] Sun Moyi, Guo Wei, Ran Wei, et al. Expert consensus on perioperative venous thromboembolism assessment and prevention in oral and maxillofacial surgery [J]. Journal of Practical Stomatology, 2021, 37 (03): 293-302.

[38] Sibai H, Chen R, Liu X, et al. Anticoagulation reduces venous thromboembolism rate in adult acute lymphoblastic leukaemia treated with prophylaxis with asparaginase-based therapy. Br J Haematol. 2020; Epub May 13. doi: 10.1111/bjh.16695.

[39] Temraz S, Moukalled N, Gerotziafas GT, etal.Association between Radiotherapy and Risk of Cancer Associated Venous Thromboembolism: A Sub-Analysis of the COMPASS-CAT Study [J]. Cancers (Basel), 2021, 13 (5): 1-10.

[40] Guy JB, Bertoletti L, Magne N, et al.Venous thromboembolism in radiation therapy cancer patients: Findings from the RIETE registry [J].Crit Rev Oncol Hematol, 2017, 113:83-89.

[41] Leith JT, Hercbergs A, Kenney S, Mousa SA, Davis PJ. Activation of tumor cell integrin avb3byradiationandreversalation of activation by modified tetraiodothyroacetic acid (Resac). Endocr Chemical. 2018; 43 (4): 215-219.